Sometimes patients can articulate, and sometimes they have trouble. I think trying to understand what the barriers for that particular patient are is really the first step, because it's different for everyone. As medication adherence is already a struggle for many patients with HIV for a variety of reasons, what can clinicians do to improve treatment adherence for patients with HIV-associated neurologic disorders? Your presentation highlights a case of toxoplasmosis that recurred after the patient was nonadherent to their treatment plan. Different barriers patients face can contribute to medication nonadherence in people with HIV, and there are different levels of support available, says Jessica Robinson-Papp, MD, MS, professor of neurology at Icahn School of Medicine at Mt.
0 Comments
Leave a Reply. |